AbbVie Inc. vs PTC Therapeutics, Inc.: Annual Revenue Growth Compared

Pharma Giants: AbbVie vs PTC Revenue Growth Battle

__timestamp	AbbVie Inc.	PTC Therapeutics, Inc.
Wednesday, January 1, 2014	19960000000	22963000
Thursday, January 1, 2015	22859000000	36766000
Friday, January 1, 2016	25638000000	82705000
Sunday, January 1, 2017	28216000000	194392000
Monday, January 1, 2018	32753000000	264734000
Tuesday, January 1, 2019	33266000000	306980000
Wednesday, January 1, 2020	45804000000	380766000
Friday, January 1, 2021	56197000000	538593000
Saturday, January 1, 2022	58054000000	698801000
Sunday, January 1, 2023	54318000000	937822000

Unleashing insights

AbbVie Inc. vs PTC Therapeutics, Inc.: A Decade of Revenue Growth

In the ever-evolving pharmaceutical landscape, revenue growth is a key indicator of a company's success and market position. Over the past decade, AbbVie Inc. has demonstrated a robust growth trajectory, with its revenue increasing by approximately 172% from 2014 to 2023. This growth is a testament to AbbVie's strategic acquisitions and strong product pipeline. In contrast, PTC Therapeutics, Inc., while significantly smaller, has shown impressive growth, with its revenue surging by over 3,900% during the same period. This remarkable increase highlights PTC's innovative approach and successful product launches. The data underscores the dynamic nature of the pharmaceutical industry, where both established giants and emerging players can thrive through innovation and strategic planning.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025